Obesity has been an epidemic in the US and world for more than two decades. Obesity is associated with serious health conditions, including type 2 diabetes, cardiovascular disease, certain types of cancers, hyperlipidemia, and liver steatosis. The intestinal microbiota is composed of a diverse population of obligate and facultative anaerobic microorganisms, and these organisms carry out a broad range of metabolic activities. Obesity has been linked to changes in the intestinal microbiota, but the composition of the bacterial populations in lean and obese Zucker rats has not been carefully studied. The objective of this study was to determine the effects of obesity on the gut microbiota in this model. Lean and obese female Zucker rats (n = 16) were fed an AIN-93G diet for 8 weeks. Rats were weighed twice weekly, and fecal samples were collected at the beginning and end of the experiment. 16S rRNA gene sequencing was used to evaluate the composition of the fecal bacterial populations. At the outset of the study, the lean rats exhibited much lower ratios of the Firmicutes to Bacteroidetes phyla than the obese rats, but after 60 days, this ratio in the lean rats exceeded that of the obese. Obese rats also showed increased levels of the genus Akkermansia at day 60. PCoA plots of beta diversity showed clustering of the different test groups, indicating clear differences in intestinal microbiota populations associated with both the time point of the study and the lean or obese status. Since obesity is linked to the risk of development of different chronic diseases, this model would be valuable for investigation of the interrelationship of obesity and the intestinal microbiota on the development of several human obesity-related diseases. The benefit of using this obese model is that rats become obese in a short period of time which provides a better translation to obese humans.
Abstract
Maternal over nutrition may induce multiple pathologies both in the mother and in the offspring. The risk of these diseases has a direct relation to the degree of overweight or severity of maternal obesity. A poor quality of nutrition, by either excess or restriction, can disrupt the ovarian function, especially the development and quality of oocytes. Therefore, we studied the effect of maternal overweight and obesity on the ovarian reserve, follicular development, and ovulation of the offspring and to assess whether this maternal condition is able to alter oocyte integrity. To this end, female offspring from rats fed standard (OSD) or cafeteria (OCD) diet were used. Cafeteria feeding from weaning mimics the eating habits of many people from an early age and is effective inducing obesity. To relate the effects observed in the offspring to the different degree of overweight of their respective mothers, offspring were divided into 3 groups: offspring from rats with standard diet (OSD), and offspring from rats with 17% and 28% overweight (OCD17 and OCD28, respectively). Body weight, vaginal opening, and estrous cycle were recorded, and ovaries were obtained on the day of the second estrus. In addition, ovarian weight, ovulation rate (measured by the number of oocytes within oviducts), follicular development (determined by histology), hormone levels and oocyte integrity were examined. Both OCD groups showed higher body weight, but OCD28 also exhibited early vaginal opening and higher ovarian weight and glycemia at euthanasia compared with OSD. Both OCD17 and OCD28 had lower number of primordial and primary follicles, and only OCD28 exhibited lower number of antral follicles, all compared with OSD rats. In addition, both OCD17 and OCD28 had higher ovulation rate than controls, and OCD28 had lower number of healthy oocytes, which, in turn, exhibited morphological alterations such as larger perivitelline space, zona pellucida than those of control animals. Moreover, some oocytes from OCD28 were deformed and exhibited irregular membranes. Likewise, both OCD groups exhibited changes in the serum levels of hormones, including anti-Mullerian hormone. These results indicate that maternal overweight may severely affect the reproductive ability of the offspring, as a result of inducing i) early puberty, ii) high rate of follicle loss, which means less follicular reserve, iii) risk of premature ovarian aging, iv) poor oocyte quality, and v) hormonal imbalance. 
Periodontal Diseases and

Abstract
Imidazolones are the important class of heterocylces which includes many compounds with biological and chemical interest. Diverse biological activities such as anti-inflammatory, antimicrobial is associated with this nucleus. Several 2-imidazolone derivatives are biotin antagonists and are capable of inhibiting the growth of malignant tumors. In the view of above observations our previously synthesized imidazolone thiocarbamides as CNS anticonvulsants and Mao inhibitors (J International Academic Research for Multidisciplinary. 2016 4: 103-109.) were evaluated by pharmacophore modeling as antiadipogenic and antiobesity agents. The previously developed pharmacophore model was used to predict the antihyperlipidemic activity of novel compounds. The pharmacophore model was developed using the known compounds from the dataset of 10 potent compounds with activity range between IC501900-5nM. In this study we reported a novel series of compounds belonging to the substituted imidazolone thiocarbamide derivatives using the Hip-hop module of catalyst software. The test set of 16 prioritized compounds from the library of 200 compounds was used against the pharmacophore query. The basis of selection is the fit value criteria ranging from 3-5. Series were showing good to moderate activity predicted as antihyperlipidemic through HMG-CoA inhibition. The selected series was again validated for the further validation for antiadipogenic activity. The already published model (Journal of Lipid Research. 2014 55(6): 1019-1032.) is used to study the probable antiadipogenic activity of the selected series of ligands. The predicted most active ligand from the training set was considered to bind in the similar fashion as that of standard at the receptor active site. 
CDK6 Inhibits
Abstract
Obesity increases the mortality and morbidity of cancers, yet the underlying mechanisms remain elusive. Acute myeloid leukemia (AML) is a lethal disease for most patients. However, the knowledge gap on molecular causes of AML progression hampers the development of effective quality improvement interventions. Here, we show that high-fat diet-induced obese mice exhibit elevated levels of fatty acid binding protein 4 (FABP4), interleukin-6 (IL-6), DNA methyltransferase 1 (DNMT1) and global DNA methylation compared to lean subjects. Upregulation of FABP4 and DNMT1 is positively correlated and predicts poor prognosis in AML patients. Importantly, leukemia burden is much higher in obese AML patients and in high-fat dietinduced obese mice than lean counterparts. We demonstrate that obesity-related FABP4 upregulation accelerates AML growth through IL-6-dependent DNMT1 overexpression and subsequent methylation-silenced tumor suppressor gene p15INK4B in AML cells. In addition, DNMT1 upregulation increases VEGF-mediated FABP4 production. Further, FABP4 blockade, either by siRNA, by a selective inhibitor BMS309403 or by genetic deletion, suppresses AML cell colony formation, induces cell differentiation and impairs leukemic disease progression in mouse models of leukemia. Mechanistically, FABP4 deactivation results in global and gene specific DNA hypomethylation and reactivation of p15INK4B. Our findings reveal a vicious loop of FABP4/DNMT1 in the control of AML cell fate in obesity and provide a strong rationale for developing epigenetic therapies that use FABP4 inhibitors alone or in combination with other treatments. Because deregulation of FABP4 and DNA methylation is observed in other cancers, this approach may be extended to the treatment of other human malignancies.
Low Level Laser to Improve Fat Loss in Patients on VLC Ketogenic Diet Cesar Lara
Center for Weight and Age Management, FL, USA
Abstract
I have dedicated the last 15 years of my professional life to the understanding of the etiology and treatment of obesity, and in the process empower patients to take control of their lives by learning the principles of healthy eating and lifestyle modification. In my pursuit I developed an interest in new technologies that can augment and improve the release of excess fat, specifically for weight-loss but also for contouring the body. In that realm, I discovered the low-level green light laser by Verju, which has had remarkable results in three level 1 double blind clinical studies. When I first discovered it at a conference of the Obesity medicine association, I thought it was too good to be true. How can a person be put under a laser light, have no risk of problems, and in 6 treatments of 30 minutes over two weeks loose an average of 6.2 inches of fat? And to my astonishment these level one studies, required that the patients not change their usual and customary diets or their exercise routines, if they were doing anything at all. As I did my due diligence, I was happy to know that the studies were legit and subsequently acquired one for my clinics. Over the past 16 months, we have been using the Verju in patients that just walk into the practice and want to contour their bodies or to lose inches of fat, the majority do our weight management program which comprises of a very low calorie ketogenic nutritional plan. Having been in bariatric practice full time with multiple centers in Florida, speaks to the success of our nutritional plan and program. However, since adding the low laser as an option for patients, we have seen significant improvement in the inches of fat loss. The beauty of the low laser is that it is non-invasive, has no down time and for those that are not interested in going through a rigorous lifestyle modification, say a patient who needs to get into an outfit for a weeding in 3 weeks, we can help them with minimal requirements from their usual and customary habits. However, those results may not last long as they didn't change their ways and the inflammatory obesogenic diet will eventually get the best of them. On the other hand, for those that do want to change their lifestyle and do our program, they will see faster and long-lasting results.
From a medical perspective, I like the fact that when doing a ketogenic diet and using the low-level laser, their fat loss is greater, and the ratio of muscle loss is less. These patients actually loose fat primarily and hence a bigger volume or more inches lost. The patients are very happy, as they see results. As an added benefit the low-level laser is also been helpful in contouring to help get rid of fat bulges in the tummy, arms, hips, thighs, buttocks and love handles. Plus, it also helps smooth out skin, and as such it has level 1 double blind studies supporting the effectiveness in treating cellulite as well. In conclusion, I intend to share the success of ketogenic nutritional plan and the use of low level laser to improve fat loss. 
Overweight and obesity are chronic noncommunicable diseases that have generated a worldwide pandemic of multifactorial etiology. These conditions can occur from childhood to adulthood. Overweight children are more likely to become obese adults with a high probability of suffering complications, including disability or premature death. According to WHO as of October 2017, about 2.8 million people die from overweight or obesity; however, people who suffer from them during their life suffer complications or consequences derived from these pathologies. Programs in the health and education sector have been considered for the prevention and treatment of overweight and obesity. It has been shown that physical activity, in addition to influencing as a protective factor against metabolic diseases, helps weight loss by an integration of regular exercise at a certain intensity in daily life. Physical activity will then achieve that the subject who carries out a workout in order to lose body fat, gain lean mass and improve their physical fitness, making it healthy and improving in turn the different systems of the body that collaborate substantially in the ideal achievement of daily activities, optimizing the quality of life of the subject. Blueberry fruit is one of the important antioxidant resources due to the content of anthocyanins and phenolic substances. While positive changes were observed in all values in both groups, significant differences in the intervention group were observed in BMI, insulin levels, insulin resistance, LDL, total cholesterol, and uric acid levels. At end of the trial, total cholesterol values had changed between 178.59 ± 29.42 mg/dL; 173.20 ± 33.26 mg/dL for control and blueberry groups respectively. LDL and total cholesterol (18.3-14.75%) values were found statistically significant at the end of 12 weeks in the group which added blueberries to replace carbohydrates. 
Prevalence of Obesity, Diabetes Mellitus, Hypertension and Associated Risk Factors in a Mining
Analysis of the
Abstract
As in many other developed nations, the problem of obesity is acute in Russia, where its prevalence is 24.1% of the population (28 million people). Sibutramine, orlistat, liraglutide are all used as a pharmacotherapy of the disease. Since the administration of central-acting drugs as pharmacotherapy of obesity is the most pathogenetically justified the issue of safety of sibutramine therapy is very important. In order to implement the principles of active monitoring of the efficacy and safety of the sibutramine (Reduxin ® ) in the current clinical practice and to develop a skill of reasonable prescribing the observation program "PRIMAVERA" was conducted since November 2012 to July 2015 under the auspices of Endocrinology Research Centre and the Russian Association of Endocrinologists (NCT01773733, clinicaltrial.gov). The program "PRIMAVERA" was attended by 3095 doctors of various specialties and 98.774 patients being treated in 1272 hospitals in 142 Russian cities. The duration of Reduxine ® treatment was determined by the attending physician and ranged from 3 months to 1 year. The BMI reducing dynamics during 3, 6, 12 months was 3.4 ± 1.53 kg/m 2 (average 9.5 ± 4.28 kg), 5.4 ± 2.22 kg/m 2 (15.0 ± 6.22 kg), 7.2 ± 3.07 kg/m 2 (20.0 ± 8.62 kg) respectively. The average waist circumference reduction for 3, 6 and 12 months was 6.3 ± 4.31 sm, 10.6 ± 6.30 sm, 16.0 ± 8.94 sm, respectively. It was shown that the weight loss during prolonged (more than six months) Reduxine ® therapy under the supervision of a physician was associated with decreased levels of systolic and diastolic blood pressure and had no effect on heart rate. In "PRIMAVERA" program it was shown that the use of Reduxine ® (sibutramine) according to approved indications is safe and effective for long-term treatment of obesity.
We recently reported that male compared with female rats are less responsive to long-term central leptin overexpression, as assessed by decreased food intake and delta body weight. Moreover, males were more susceptible to development of leptin resistance than females suggesting that either male hormones mitigate, or female hormones exacerbate leptin responses or both. To address the potential role of estradiol, we centrally delivered a viral vector to overexpress ether leptin or green fluorescence protein (GFP) into male rats that were simultaneously treated with either estradiol (25 μg/kg; S.C., daily) or vehicle in a two x two design. We examined chronic changes in food intake (FI), body weight (BW) and body composition over 26 days. BWs in both Leptin-vehicle and GFP-Estradiol were reduced compared with GFP-vehicle and more sustained in Leptin-Estradiol reminiscent of the pattern in females. Changes in FI were unique to each treatment, with a rapid decrease in Leptin-vehicle followed by gradual renormalization typical of leptin-induced leptin resistance in male rats. In contrast, the GFP-Estradiol decrease in FI was of lower amplitude (P < 0.001) but sustained over the 26 days (P < 0.003). The Leptin-Estradiol group was mostly additive with a delay in leptin resistance typical of the pattern observed in female rats. Decreased body fat by TD-NMR was unique to each treatment paralleling FI. Phosphorylation of STAT3 (P-STAT3) was examined at death. No exogenous leptin was administered, thus detected P-STAT3 was due to central overexpressed leptin. P-STAT3 was greater in both leptin groups compared with GFP, but there was no difference between Leptin-vehicle and Leptin-Estradiol. In conclusion, these data suggest that leptin and estradiol both decrease FI and BW through different mechanisms, with the pattern of Leptin-Estradiol reminiscent of that observed in females. Furthermore, the estradiol-induced decrease in FI & BW does not involve P-STAT3. These data suggest that estradiol may be one factor in the increased leptin response and mitigated leptin resistance observed in female rats.
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to determine the relationship between osteoporotic vertebral fracture and body mass index (BMI) by comparing it with other types of osteoporotic fractures.
Summary of Literature Review: Several authors have reported the factors that predict the risk of osteoporotic vertebral fracture in individuals with obesity, but the objective risk factors are still controversial.
Materials and Methods:
A retrospective study was conducted on postmenopausal women, including 100 people with osteoporotic vertebral fractures, 104 with femur neck fractures, 107 with distal radius fractures, and 103 with osteoporosis or osteopenia but without fractures. The BMI was calculated and bone mineral density (BMD) test was administered within 3 days after injury. For each type of fracture, the relationships with age, height, weight, BMI, and BMD were investigated. The relationship with the number of osteoporotic vertebral fractures according to BMI was also evaluated.
Results: In comparing osteoporotic vertebral fractures and osteoporotic non-vertebral fractures, there were no significant differences in the relationship with age, height, or BMD (p > 0.05). Osteoporotic vertebral fractures showed a statistically higher average weight and BMI, compared to other osteoporotic non-vertebral fracture groups (p < 0.05). Among those with osteoporotic vertebral fractures, the number of fractures did not show a significant relationship with BMI (p = 0.177).
Conclusions:
In osteoporotic vertebral fracture patients, compared to groups with other types of osteoporotic fractures, average weight and BMI were higher.
The Pathogenesis of Interleukin-22 and Its Receptor in UVB-Induced Skin Inflammation
Yejin Kim * and Jae Seung Kang
Seoul National University College of Medicine, South Korea
Abstract IL-22 plays a pathogenic role in acute and chronic skin diseases. In addition, UVB, which affects the skin, is linked to various diseases, including obesity. Unlike IL-22 produced in immune cells, the expression IL-22Rα, a functional subunit of IL-22R, is mostly restricted to non-hematopoietic cells in organs like skin and pancreas. Although it is well known that UVB induces skin inflammation, there have been no reports regarding the role of UVB in regulating the expression of IL-22Rα receptor so far. IL-22Rα is increased in HaCaT and primary human keratinocytes after UVB irradiation through the translocation of IL-22Rα from the cytosol to the membrane. We also found that increase in the expression of IL-22Rα is mediated by the activation of the PI3K/Akt pathway. Moreover, the suppressed proliferation of keratinocytes caused by UVB irradiation can be recovered with an IL-22 treatment. The increased expression of IL-22Rα is closely related with the proliferation of keratinocytes and the production of inflammatory cytokines (IL-1α, -6 and -18), during UVB-induced skin inflammation. It suggests that UVB facilitates skin inflammation by increasing the expression of IL-22Rα in keratinocytes. Therefore, our study provides a new insight into UVB-induced skin inflammation and the regulation of related diseases. 
Utilizing an Assessment of Eating
Abstract
Introduction: The aim of our non-blinded study is to evaluate the outcome of Shared Decision-Making (SDM) versus Usual Decision-Making (UDM) in these two minority populations in the Bronx. This study provides support to the value of using SDM techniques as an effective method for behavioral change that Physicians can incorporate into their practice. Our novel research approach applies the SDM method to Latin and AA populations. This Phase II trial allowed us to identify and confirm domains where these two populations can effectively modify their behaviors to improve their BMI, blood pressure and reduce their risk for cardiovascular disease.
Methods: A prospective randomized non-blinded pilot study was conducted using validated questionnaires that collected quantitative data. The Eating Pattern Questionnaire was chosen to evaluate Diet Quality and Frequency, Snack Intervals, and Fluid Intake. Meal frequency was determined by asking the patient which meals and snacks they consumed each day. Patients were randomly assigned into the UDM or SDM groups. Patients then received previously validated treatment recommendations
